Christopher M. Smith

Insider Reports History

Identity 1 fact
Location
Menlo Park, CA
SEC filing record 1 fact
SEC signature
/s/ Michele Farmer, Attorney-in-fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Christopher M. Smith:

Form 4 holding Chief Executive Officer

NEOGENOMICS INC

Security class
Common Stock
Shares / value
641,585
Estimated value
$9,853,142
Report date
23 Feb 2025
Price
$15.36
Ownership
Direct
Form 4 holding Chief Executive Officer

NEOGENOMICS INC

Security class
Performance Stock Unit
Shares / value
172,240
Estimated value
$2,645,176
Report date
23 Feb 2025
Price
$15.36
Ownership
Direct
Underlying class
Common Stock
Underlying amount
172,240
Form 4 holding Director

QuidelOrtho Corp

Security class
Common Stock
Shares / value
33,328
Estimated value
$2,306,964
Report date
06 Jun 2023
Price
$69.22
Ownership
By Trust
Form 4 holding Chief Executive Officer

NEOGENOMICS INC

Security class
Restricted Stock Unit
Shares / value
114,826
Estimated value
$1,763,440
Report date
23 Feb 2025
Price
$15.36
Ownership
Direct
Underlying class
Common Stock
Underlying amount
172,239
Form 4 holding Chief Executive Officer

NEOGENOMICS INC

Security class
Restricted Stock Unit
Shares / value
96,127
Estimated value
$1,428,447
Report date
11 May 2024
Price
$14.86
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

QuidelOrtho Corp

Security class
Common Stock
Shares / value
2,249
Estimated value
$155,676
Report date
06 Jun 2023
Price
$69.22
Ownership
Direct
Form 4 holding Chief Executive Officer

NEOGENOMICS INC

Security class
Stock Option (Right to Buy)
Shares / value
287,940
Estimated value
Report date
23 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
287,940
Form 4 holding Director

Akouos, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,000
Estimated value
Report date
23 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman and CEO, Director

Ortho Clinical Diagnostics Holdings plc

Security class
Stock Option
Shares / value
0
Estimated value
Report date
27 May 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares, $0.00001 par value
Underlying amount
Form 4 holding Director

QuidelOrtho Corp

Security class
Restricted Stock Units (Equity Grant)
Shares / value
0
Estimated value
Report date
06 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher M. Smith

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .